home *** CD-ROM | disk | FTP | other *** search
- $Unique_ID{BRK04181}
- $Pretitle{}
- $Title{Retinopathy, Hypertensive}
- $Subject{Retinopathy Hypertensive }
- $Volume{}
- $Log{}
-
- Copyright (C) 1987, 1989 National Organization for Rare Disorders, Inc.
-
- 328:
- Retinopathy, Hypertensive
-
- ** IMPORTANT **
- It is possible the main title of the article (Hypertensive Retinopathy)
- is not the name you expected. Please check the SYNONYMS listing on the next
- page to find alternate names and disorder subdivisions covered by this
- article.
-
- Synonyms
-
- Information on the following diseases can be found in the Related Disorders
- section of this report:
-
- Papilledema
-
- General Discussion
-
- ** REMINDER **
- The information contained in the Rare Disease Database is provided for
- educational purposes only. It should not be used for diagnostic or treatment
- purposes. If you wish to obtain more information about this disorder, please
- contact your personal physician and/or the agencies listed in the "Resources"
- section of this report.
-
-
- Hypertensive Retinopathy is a syndrome of changes in the retina caused by
- high blood pressure (hypertension). It is characterized by progressive
- changes in the little arteries (arterioles) of the eye and swelling (edema),
- resulting in impairment of vision.
-
- Symptoms
-
- During the early stages of Hypertensive Retinopathy, constriction of the
- arterioles of the retina occurs. As the disease progresses, superficial
- flame-shaped hemorrhages and spots that look like cotton wool (white or grey
- foci) appear in the eye. During the latter stages of the disorder, the optic
- disc, as seen by ophthalmoscopic examination, may appear to be slightly
- blurred or swollen (papilledema).
-
- Causes
-
- Hypertensive Retinopathy occurs as a result of high blood pressure over a
- long period. In some cases it may occur in pregnant women (eclampsia or
- preeclampsia).
-
- Affected Population
-
- Hypertensive Retinopathy affects persons with chronic essential hypertension.
- If untreated, the blood pressure usually rises with age and the retinopathy
- tends to become more severe up to the age of 50 years. Severe hypertensive
- retinopathy is more common in the black population.
-
- In Hypertensive Retinopathy in pregnant women (Eclampsia or
- Preeclampsia), the incidence is usually higher in women of African ethnic
- heritage, persons from lower socioeconomic groups, persons in the
- southeastern part of the United States, and people who live in the
- Philippines.
-
- Related Disorders
-
- Papilledema (Choked Disk) is a swelling (edema) of the portion of the retina
- where the optic nerve enters the eyeball. The swelling is due to increased
- pressure inside the skull that may be caused by a variety of conditions.
-
- Therapies: Standard
-
- Therapy for Hypertensive Retinopathy consists of treating the underlying
- hypertension with antihypertensive drugs. If the blood pressure can be kept
- under control, this condition may not develop or be reversed.
-
- Therapies: Investigational
-
- This disease entry is based upon medical information available through March
- 1987. Since NORD's resources are limited, it is not possible to keep every
- entry in the Rare Disease Database completely current and accurate. Please
- check with the agencies listed in the Resources section for the most current
- information about this disorder.
-
- Resources
-
- For more information on Hypertensive Retinopathy, please contact:
-
- National Organization for Rare Disorders (NORD)
- P.O. Box 8923
- New Fairfield, CT 06812-1783
- (203) 746-6518
-
- NIH/National Eye Institute
- 9000 Rockville Pike
- Bethesda, MD 20892
- (301) 496-5248
-
- Eye Research Institute of the Retina Foundation
- 20 Staniford Street
- Boston, MA 02114
- (617) 742-3140
-
- American Foundation for the Blind (AFB)
- 1010 Vermont Ave., NW, Suite 1100
- New York, NY 10011
- (202) 393-3666
-
- American Heart Association
- 7320 Greenville Ave.,
- Dallas, TX 75231
- (214) 750-5300
-
- References
-
- MERCK MANUAL OF DIAGNOSIS AND THERAPY: Robert Berkow, et al, eds; Merck,
- Sharp & Dohme Research Laboratories, 1982. Pp. 392, 2011.
-
-